Implementation For Phase 3 eMERGE |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Geisinger |
Case, Control |
25 |
25 |
100%, 96% |
|
Geisinger Impl |
Colorectal Cancer (CRC) |
Geisinger |
Case, Control |
25 |
25 |
100%, 100% |
|
Geisinger caMRSA Implementation |
caMRSA |
Geisinger |
Case, Control |
25 |
25 |
96%, 100% |
96% |
Group Health and UW Zoster Implementation |
Herpes Zoster |
Group Health and UW |
Case, Control |
25 |
25 |
100%, 96% |
100% |
Marshfield AAA implementation |
Abdominal Aortic Aneurysm ( AAA ) |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
22 |
100%, 100% |
|
Geisinger c.Diff eMERGE3 Implementation |
Clostridium Difficile Colitis |
Geisinger |
Case, Control |
20 |
20 |
100%, 100% |
100%, 100% |
Appendicitis Case 1, Control |
Appendicitis |
Cincinnati Children's Hospital Medical Center |
Case, Control |
15 |
20 |
93%, 100% |
|
Validation of Asthma algorithm - Geisinger |
Asthma |
Geisinger |
Case, Control |
10 |
10 |
100%, 100% |
|
Marshfield C-diff implementation |
Clostridium Difficile Colitis |
Marshfield Clinic Research Foundation |
Case, Control |
21 |
10 |
100%, 100% |
|
Marshfield Zoster implementation |
Herpes Zoster |
Marshfield Clinic Research Foundation |
Case, Control |
10 |
10 |
100%, 100% |
|
Early Childhood Obesity Implementation - Columbia |
Severe Early Childhood Obesity |
Columbia University |
Case, Control |
2 |
3 |
|
|
CHOP Post-event Pain |
Post-event Pain algorithm |
CHOP |
Case, Control |
99 |
2 |
96% |
|
Mayo SLE Implementation |
SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria |
Mayo Clinic |
Case, Control |
0 |
0 |
|
|
Atopic dermatitis implementation - Marshfield |
Atopic Dermatitis Algorithm |
Marshfield Clinic Research Foundation |
Case, Control |
|
|
96%, 90% |
|
Demonstration Project RA Implementation |
Rheumatoid Arthritis - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
97%, 100% |
|
Pneumonia_data_4_7_institutes |
Pneumonia- VUMC eMERGE v5.1 |
|
Case Only |
|
|
|
|
Geisinger eMERGE3 Combined Implementation |
Diverticulosis and Diverticulitis |
Geisinger |
Case, Control |
|
|
97%, 94% |
|
Columbia Lupus Implementation |
SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria |
Columbia University Medical Center |
Case, Control |
|
|
|
|
NAFLD_Mayo clinic implementation |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
Mayo Clinic |
Case, Control |
|
|
|
|
CHOP implementation Case 1 and Controls |
Appendicitis |
CHOP |
Case, Control |
|
|
86%, 100% |
|
Mayo implementation |
Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) |
Mayo Clinic |
Case Only |
|
|
|
|
Cataracts-Columbia |
Cataracts |
Columbia University |
Case Only |
|
|
|
|
Anxiety - CCHMC |
Anxiety algorithm |
Cincinnati Children's Hospital Medical Center |
Case, Control |
|
|
100%, 100% |
|
NU FH 2018 with chart reviewed family hx and NLP for FH sx |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Northwestern University |
Case Only |
|
|
|
|
CHOP Part II- NONRESPONDERS |
Epilepsy/Antiepileptic drug response algorithm |
CHOP |
Case Only |
|
|
85% |
|